戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 s to assess whether there are differences in multiparametric (18)F-FDG PET/MRI biomarkers of contrala
2                   Conclusion: Differences in multiparametric (18)F-FDG PET/MRI biomarkers, obtained f
3                                              Multiparametric 3-T MRI (T2-weighted, diffusion-weighted
4 nical trial, hybrid (18)F-choline PET/CT and multiparametric 3T MRI (mpMRI) of the pelvis were perfor
5            We develop and test a Microscopic Multiparametric Analysis by Phasor projection of Polariz
6                           Here, we present a multiparametric analysis of clinical immunology data col
7                                          Our multiparametric analysis revealed that a group of glutam
8                                              Multiparametric analysis showed that classified voxels w
9 valuated using an original strategy based on multiparametric analysis, taking into account growth rat
10 rative MR imaging features (n = 31) included multiparametric (anatomic and diffusion-, perfusion-, an
11       Purpose To evaluate the association of multiparametric and multiregional magnetic resonance (MR
12                               We expect this multiparametric and rapid phenotyping approach to accele
13                                  An unbiased multiparametric and traditional manual analysis of T-cel
14                                    We used a multiparametric approach combining flow cytometry, confo
15                                          The multiparametric approach contained dynamic contrast enha
16                                          Our multiparametric approach has highlighted repercussions o
17 the identification of tumors improved with a multiparametric approach versus a strictly T2-weighted o
18                      This technique offers a multiparametric approach, providing an overview of the p
19                         The recent advent of multiparametric approaches for myocardial deformation im
20                        Thus, the approach of multiparametric bioelectronic monitoring offers capabili
21                           Moreover, the same multiparametric bioelectronic platform can be used in co
22 e we apply a machine learning algorithm to a multiparametric brain PET imaging dataset acquired in a
23  enhancing lesions as benign or malignant at multiparametric breast MRI.
24 -enhancing lesions as benign or malignant at multiparametric breast MRI.
25 doxorubicin-induced cardiotoxicity by serial multiparametric cardiac magnetic resonance (CMR) and its
26  development and longitudinal application of multiparametric cardiac magnetic resonance imaging (MRI)
27 ents with takotsubo cardiomyopathy underwent multiparametric cardiac magnetic resonance imaging, incl
28                   Purpose To derive and test multiparametric cardiac MRI models for the diagnosis of
29                                   Conclusion Multiparametric cardiac MRI models have high diagnostic
30 ertrophy [LVH]) and 27 healthy controls with multiparametric cardiovascular magnetic resonance includ
31                    These are quantifiable by multiparametric cardiovascular magnetic resonance.
32 rent diffusion coefficient (ADC) mapping for multiparametric characterization of prostate disease.
33  with chemometrics is developed, providing a multiparametric characterization of vitreous humor as a
34                                            A multiparametric chemical optimization approach allowed t
35                                        Next, multiparametric classification was performed using lesio
36               Cardiac damage detectable by a multiparametric CMR approach can occur early in thalasse
37           This study aims at a retrospective multiparametric CMR assessment of myocardial iron overlo
38           Within 1 month, patients underwent multiparametric CMR, including assessment of regional an
39 sonance (MR) imaging in comparison with full multiparametric contrast material-enhanced prostate MR i
40 rsion 2; only thereafter, the remaining full multiparametric contrast-enhanced MR images were read.
41 ) first reviewed only a fraction of the full multiparametric contrast-enhanced MR images, consisting
42 .1%, 483 of 542) was similar to that of full multiparametric contrast-enhanced MR imaging (87.2%, 473
43                                         Full multiparametric contrast-enhanced MR imaging allowed det
44 r detection rate of biparametric versus full multiparametric contrast-enhanced MR imaging and between
45 sy findings underwent state-of-the-art, full multiparametric contrast-enhanced MR imaging at 3.0-T in
46 are equivalent to those of conventional full multiparametric contrast-enhanced MR imaging protocols.
47 olume, shape, and texture features) from the multiparametric (contrast material-enhanced T1-weighted
48                                 We performed multiparametric cytofluorimetric analysis of PD-1(+) NK
49 lysis and allows the unbiased acquisition of multiparametric data at the single-cell level for hundre
50                   Here, we report the use of multiparametric data extracted from a single marker and
51                   However, the evaluation of multiparametric data generated via time-of-flight mass c
52                         Diagnostic values of multiparametric, DCE MR imaging, and DWI were calculated
53  tissues to be more effectively probed using multiparametric deep-tissue bioluminescence imaging.
54 both protein and nucleic acid biomarkers for multiparametric diagnostic assays.
55 urpose To evaluate the cost-effectiveness of multiparametric diagnostic magnetic resonance (MR) imagi
56                                              Multiparametric diagnostic models integrating different
57                                  Preclinical multiparametric diagnostics could help discover clinical
58 n online appendix, with proposals for future multiparametric directions to improve performance on the
59 AO-mediated metabolism should be part of the multiparametric drug optimization process, with the goal
60 ime window of thrombolysis was comparable to multiparametric DWI-FLAIR MRI.
61 crosensor, based on a polymer substrate, for multiparametric, electrochemical in vivo monitoring.
62 men (mean age, 66.2 years +/- 6.9) underwent multiparametric endorectal prostate MR imaging at 3 T an
63                               In conclusion, multiparametric evaluation of the spatial distributions
64    The results were contrasted with those of multiparametric flow cytometry (MFC) and allele-specific
65 at distinct risk; by contrast, low-sensitive multiparametric flow cytometry (MFC) immunophenotyping (
66                                              Multiparametric flow cytometry (MFC) in amyloid light-ch
67                                            A multiparametric flow cytometry analysis was performed to
68 secretion in the ELISpot was confirmed using multiparametric flow cytometry and largely attributed to
69                           Through the use of multiparametric flow cytometry established by the Europe
70                                              Multiparametric flow cytometry for quantitation of labil
71                                  Advances in multiparametric flow cytometry have revealed that the fu
72    Pre-HCT disease staging included 10-color multiparametric flow cytometry on bone marrow aspirates
73                                              Multiparametric flow cytometry on peripheral blood T cel
74           In this protocol, we describe five multiparametric flow cytometry panels that can be used a
75                                      We used multiparametric flow cytometry to analyze whole peripher
76                                      We used multiparametric flow cytometry to count 14 subsets of pe
77 extensive functional immunophenotyping using multiparametric flow cytometry to examine peripheral imm
78 %-100%]), 11 of 12 (92% [95% CI, 62%-100%]) (multiparametric flow cytometry), 14 of 21 (67% [95% CI,
79                                      We used multiparametric flow cytometry, functional NK cell assay
80                             Methods: We used multiparametric flow cytometry, gene expression analysis
81 Taking this into account, we analyzed, using multiparametric flow cytometry, the co-expression of the
82 ch of high-throughput TCRbeta sequencing and multiparametric flow cytometry, we compared the TCR repe
83  25 HIV-infected patients (3-19 years) using multiparametric flow cytometry.
84 -remitting multiple sclerosis patients using multiparametric flow cytometry.
85  M. tuberculosis-specific CD4(+) T cells via multiparametric flow cytometry.
86 s and bronchoalveolar lavage fluid (BALF) by multiparametric flow cytometry.
87 lpha (TNF-alpha) production was analyzed via multiparametric flow cytometry.
88 y (10(-5) sensitivity threshold, assessed by multiparametric flow cytometry; both p<0.0001).
89 ow adaptation of the CSA in combination with multiparametric flow-cytometry (CSA-Flow) may enable sim
90 terial growth inhibition adopting a combined multiparametric high content screening and genomic appro
91                                    Using the multiparametric high-content imaging method, we evaluate
92 servational UK Biobank study underwent 3.0-T multiparametric (ie, three-dimensional T1-weighted diffu
93  patient comfort and increased throughput to multiparametric imaging and are evaluated and reviewed i
94 el methods for quantitative, transient-state multiparametric imaging are increasingly being demonstra
95 ity and robustness of our system on parallel multiparametric imaging at multiscale levels ranging fro
96 paving the way for the concept of multimodal multiparametric imaging for future more widespread clini
97 ssess the correlation and reproducibility of multiparametric imaging in head and neck cancer patients
98               In this research, we present a multiparametric imaging method allowing for concurrent m
99                                    Nanoscale multiparametric imaging of living bacteria reveals that
100 hodology for and investigated the utility of multiparametric imaging of tumor hypoxia and perfusion w
101                                              Multiparametric imaging of tumor perfusion and hypoxia w
102                                              Multiparametric imaging offers the opportunity to study
103                                            A multiparametric imaging phenotype vector was extracted f
104                                              Multiparametric imaging reveals that contractions consti
105                                  Noninvasive multiparametric imaging techniques are emerging tools th
106              The promise of PET/MRI includes multiparametric imaging to further improve diagnosis and
107     Such knowledge may extend the utility of multiparametric imaging to yield information regarding c
108  that it is possible to perform quantitative multiparametric imaging with heterogeneous RF fields, an
109                                           In multiparametric imaging with the integrated PET/MR scann
110 n exposure, higher soft-tissue contrast, and multiparametric imaging).
111 interaction analysis using double RNAi and a multiparametric, imaging-based assay.
112                  Using the VectraR automated multiparametric immunofluorescence technique, we quantif
113 ed fluorescent indicators (2-in-1-GEFIs) for multiparametric in vivo analyses of the phytohormone abs
114  recombinant in vivo ROS probes would enable multiparametric in vivo ROS detection.
115 d technique competent for the acquisition of multiparametric information by creating a tissue section
116    We present a novel hybrid model, based on multiparametric intensities, which combines machine lear
117      The final discharge diagnosis, based on multiparametric items, was recorded.
118  Here we propose a validated methodology for multiparametric kinase biosensing in living cells using
119 , proton and phosphorus MR spectroscopy, and multiparametric liver MR, including hepatic proton MRS,
120        Sonographic parameters combined using multiparametric logistic regression were able to differe
121                      Generating single-cell, multiparametric, longitudinal atlases and integrating th
122 adenocarcinoma in the context of colocalized multiparametric magnetic resonance (MR) imaging and hist
123                      Purpose To determine if multiparametric magnetic resonance (MR) imaging mapping
124                           Purpose To develop multiparametric magnetic resonance (MR) imaging models t
125                                              Multiparametric magnetic resonance (MR) imaging of the p
126 prostatectomy and underwent preoperative 3-T multiparametric magnetic resonance (MR) imaging, includi
127 ong peripheral zone (PZ) lesions seen at 3-T multiparametric magnetic resonance (MR) imaging.
128                                        Using multiparametric magnetic resonance (MR) techniques, we c
129                                              Multiparametric magnetic resonance imaging (mpMRI) has b
130                                              Multiparametric magnetic resonance imaging (mpMRI) has b
131                                   Pre-biopsy multiparametric magnetic resonance imaging (mpMRI) has t
132 eity in hepatocellular carcinoma (HCC) using multiparametric magnetic resonance imaging (mpMRI), and
133 s on small prostate tumors using test-retest Multiparametric Magnetic Resonance Imaging (mpMRI).
134                                              Multiparametric Magnetic Resonance Imaging (MRI) can pro
135                                 Longitudinal multiparametric magnetic resonance imaging (MRI) followi
136                                              Multiparametric magnetic resonance imaging of his prosta
137                  The increasing precision of multiparametric magnetic resonance imaging of the prosta
138                                      A novel multiparametric magnetic resonance microscopy (MRM) appr
139 itol on brain edema and oxygenation, using a multiparametric magnetic resonance-based approach (n = 1
140                                     CMR with multiparametric mapping is a promising tool to assess th
141 tiple-camera tandem-lens optical systems for multiparametric mapping of transmembrane potential, intr
142 luded volumetric MRI, diffusion imaging, and multiparametric mapping.
143 ation and utilization of metabotype data via multiparametric measurement of (i) metabolite levels, (i
144 e call FISH-Flow, allows for high-throughput multiparametric measurements of gene expression, a task
145                                   We found 2 multiparametric, metabolite-based scores linked independ
146              Flow cytometry is a ubiquitous, multiparametric method for characterizing cellular popul
147 iological and biomimetic systems for dynamic multiparametric microenvironmental control of emergent a
148 y was evaluated by comparing the AUC for the multiparametric model and the single best-performing qua
149 y considered when selecting metrics to build multiparametric models.
150 tomatized analysis, our results suggest that multiparametric molecular and functional imaging may be
151                    Non-invasive simultaneous multiparametric monitoring allows the in vivo evaluation
152  imaging-guided interventions, which provide multiparametric morphologic and functional information a
153 raphy (PET) and computed tomography (CT) and multiparametric (MP) 3-T endorectal MR imaging before ro
154 nically important prostate cancers missed at multiparametric (MP) magnetic resonance (MR) imaging.
155 res further validation as part of a prostate multiparametric (mp) MRI protocol.
156 eneity across a tumor microenvironment using multiparametric MR (mp-MR).
157 mation that maps brain networks derived from multiparametric MR data with metabolic information from
158 suspicious for cancer were identified on 3-T multiparametric MR images.
159 ample +/- 21), intermediately suspicious via multiparametric MR imaging (31 mutations per sample +/-
160 ns per sample +/- 19), mildly suspicious via multiparametric MR imaging (37 mutations per sample +/-
161  for 134 patients who underwent preoperative multiparametric MR imaging (T2 weighted, diffusion weigh
162                                              Multiparametric MR imaging (T2-weighted, dynamic contras
163 were evaluated, 110 with prostatectomy after multiparametric MR imaging and 53 with negative multipar
164 robot-assisted radical prostatectomy without multiparametric MR imaging and IFS analysis.
165 ions, and this reflected concordance between multiparametric MR imaging and resultant histopathologic
166 tiparametric MR imaging and 53 with negative multiparametric MR imaging and systematic biopsy finding
167 enabled spatial mapping between preoperative multiparametric MR imaging and the gland.
168               Conclusion Multiregion spatial multiparametric MR imaging and whole-exome radiogenomic
169                         Results Radiogenomic multiparametric MR imaging and whole-exome spatial chara
170 , and these results were similar to those of multiparametric MR imaging assessment of features in thi
171                                              Multiparametric MR imaging at 7 T of the breast eliminat
172 with prostate cancer (n = 133) underwent 3-T multiparametric MR imaging before prostatectomy.
173 ith a diagnosis of prostate cancer underwent multiparametric MR imaging before surgery for treatment.
174  the characterization of prostate lesions at multiparametric MR imaging by increasing reading specifi
175 Data System (PI-RADS) version 2 for prostate multiparametric MR imaging by using data from a multirea
176                                              Multiparametric MR imaging demonstrated either excellent
177 ent was evaluated on the basis of subjective multiparametric MR imaging features.
178                      The clinical use of 7-T multiparametric MR imaging is feasible, provides good or
179                            Conclusion Serial multiparametric MR imaging mapping can be used to evalua
180                Thus, if used clinically, 7-T multiparametric MR imaging may have potentially obviated
181                      Conclusion Quantitative multiparametric MR imaging models developed by using cor
182                             Before bilateral multiparametric MR imaging of the breast at 7 T, all pat
183 ostate-specific antigen levels who underwent multiparametric MR imaging of the prostate and subsequen
184 hted, and dynamic contrast material-enhanced multiparametric MR imaging of the prostate before radica
185  scale score, >/=3) focus at prebiopsy 1.5-T multiparametric MR imaging performed with T2-weighted, d
186 rotocol versus a standard six-pulse sequence multiparametric MR imaging protocol for detection of cli
187 e sequences compared with that of a standard multiparametric MR imaging protocol.
188 uided biopsy, suspicious lesions detected at multiparametric MR imaging were scored by five readers w
189                                              Multiparametric MR imaging with endorectal coil is super
190                                              Multiparametric MR imaging yielded a sensitivity of 100%
191  evidence of the positive clinical effect of multiparametric MR imaging-directed IFS analysis for pat
192 zation and segmentation of rectal cancers on multiparametric MR imaging.
193 ent robotic transperineal mapping biopsy and multiparametric MR imaging.
194 ere treatment-naive with endorectal coil 3-T multiparametric MR imaging.
195  (hereafter referred to as PSMA), and pelvic multiparametric MRI (hereafter referred to as pelvic MRI
196 taging of local disease by comparing it with multiparametric MRI (mpMRI) and radical prostatectomy (R
197                                              Multiparametric MRI (mpMRI) of the prostate has been ide
198  the cost-effectiveness of (18)F-choline PET/multiparametric MRI (mpMRI) versus mpMRI alone for the d
199                A combination of uPAR PET and multiparametric MRI (mpMRI) was performed, and the SUV i
200 of patients is recommended with biopsies and multiparametric MRI (mpMRI).
201 %), and 66% (19 of 29; 95% CI: 44%, 86%) for multiparametric MRI (P = .19, P = .02, and P = .17, resp
202 %), and 69% (24 of 35; 95% CI: 50%, 88%) for multiparametric MRI (P = .95, P = .14, and P = .07, resp
203  total of 310 consecutive patients underwent multiparametric MRI according to a standardized institut
204 gnostic accuracy and interrater agreement of multiparametric MRI and (68)Ga-PSMA-11 PET/MRI for the d
205 analysis of 40 consecutive men who underwent multiparametric MRI and (68)Ga-PSMA-11 PET/MRI within 6
206                                     Prostate multiparametric MRI and both cardiac and pelvic (15)O-H(
207     We then discuss the utility of prebiopsy multiparametric MRI and novel tumour markers.
208 tz and colleagues, the authors have combined multiparametric MRI and PET imaging to address the impor
209 ings rated the probability of ECE and SVI at multiparametric MRI and PET/MRI by using a five-point Li
210 sease course in MS by using a comprehensive, multiparametric MRI approach.
211                                              Multiparametric MRI can be used to direct prostate biops
212       We propose the use of patient-specific multiparametric MRI consisting of Dixon MRI and proton-d
213 ging Reporting and Data System (PI-RADS) for multiparametric MRI data acquisition, interpretation, an
214          In this study, we proposed to use a multiparametric MRI data as a sequence input for the con
215 nique improves the diagnostic performance of multiparametric MRI examinations of the prostate.
216              The addition of (18)F-DCFPyL to multiparametric MRI improved PPV by 38% overall (P = .02
217 stologic analysis and to compare with pelvic multiparametric MRI in men with biochemically recurrent
218 for (18)F-Fluciclovine PET and multisequence multiparametric MRI in the prediction of prostate cancer
219                  This work demonstrates that multiparametric MRI is a powerful tool for the assessmen
220 difference in upgrade rates as a function of multiparametric MRI lesion size (P = .53-.59) or locatio
221 precision laser ablation, patients underwent multiparametric MRI of the prostate at 48 to 72 h, follo
222                                              Multiparametric MRI of the prostate gland is a relativel
223  antigen (PSMA) ((68)Ga-PSMA-11) PET/MRI and multiparametric MRI perform similarly for local staging
224  it may be difficult to detect using current multiparametric MRI protocols.
225          The network input consisted of 1970 multiparametric MRI scans from 1008 patients recruited f
226 derived from combined (18)F-fluciclovine PET/multiparametric MRI show potential for detection and cha
227              Combined (18)F-fluciclovine PET/multiparametric MRI shows potential for improving detect
228            The area under the curve (AUC) of multiparametric MRI signal to classify lesion age <4.5 h
229                                              Multiparametric MRI signal was compared with NWU using l
230                               Comprehensive, multiparametric MRI studies are useful in this perspecti
231                   Interrater reliability for multiparametric MRI versus PET/MRI did not differ for EC
232                                  Results For multiparametric MRI versus PET/MRI in ECE detection, res
233                                          For multiparametric MRI versus PET/MRI in SVI detection, res
234          The DRs of (18)F-choline PET/CT and multiparametric MRI were 56% and 74%, respectively.
235 ltiple sclerosis from images from unenhanced multiparametric MRI with moderate to high accuracy.
236  (64)CuCl2 PET/CT, (18)F-choline PET/CT, and multiparametric MRI within 15 d of each other.
237 3 + 4; clinical stage, <=T2c; lesion size at multiparametric MRI, <=20 mm) underwent focal MRI/transr
238 /- 9 [standard deviation], 18 men) underwent multiparametric MRI, including IVIM DWI and gadoxetic ac
239 isualized in 77 men by using (18)F-DCFPyL or multiparametric MRI, with imaging detection concordance
240                                      Using a multiparametric MRI-pathologic cross-correlative approac
241 on, especially when used in combination with multiparametric MRI.
242 (18)F-DCFPyL PET/CT imaging and 3.0-T pelvic multiparametric MRI.
243 edictive value and specificity when added to multiparametric MRI.
244 ion of primary prostate cancer compared with multiparametric MRI.
245 mprove detection of recurrence compared with multiparametric MRI; however, histopathologic validation
246 onal neural network (CNN) was trained on the multiparametric MRIs of the discovery set to classify ea
247                                         This multiparametric, multiscale approach provides opportunit
248                             Here we report a Multiparametric Mutation Score (MMS) developed by combin
249 nical relevance and yield a patient Weighted Multiparametric Mutation Score (WMMS) that separates sev
250 ual acuity (BCVA); using the LogMAR scale, a multiparametric ocular surface score (OSS), and the Schi
251                                              Multiparametric optimization of early hits with moderate
252 xisting techniques, and also allows powerful multiparametric paired statistics.
253 variately associated with sensitization, but multiparametric PCA suggested a specific inflammatory re
254  to assess whether the addition of data from multiparametric pelvic MRI (mpMR) and whole-body MRI (wb
255                      Leveraging the power of multiparametric PET/MRI in this manner has the potential
256                         Here, we performed a multiparametric phenotypic characterization and unbiased
257                                        Using multiparametric phospho-flow and mass cytometry, we meas
258            Future studies should explore the multiparametric potential of MRI.
259  lack of intravital imaging tools capable of multiparametric probing of entire solid tumors with high
260 al heterogeneity in this model resulted in a multiparametric profile based on [(18)F]Fluorodeoxygluco
261 taneously, thus enabling pairwise-correlated multiparametric profiling of lymphocyte interactions ove
262                            All men underwent multiparametric prostate and VERDICT MRI.
263 standard." INTERVENTIONS: Patients underwent multiparametric prostate magnetic resonance imaging to i
264 re was 17.9% (five of 28) as determined with multiparametric prostate MRI and targeted biopsies at 6
265 4.3 years; range, 42-84 years) who underwent multiparametric prostate MRI from March 2012 to July 201
266 d inter-center/reader variability of routine multiparametric prostate MRI limit its wider adoption.
267                   Mass cytometry is a highly multiparametric proteomic technology that allows the mea
268 nse prediction when used in conjunction with multiparametric proton MRI.Published under a CC BY 4.0 l
269 del of cartilage informed by sample-specific multiparametric qMRI maps, obtained for eight osteochond
270 t a chemiluminescence immunoassay (CLIA) for multiparametric quantification of specific IgE to penici
271       Although we agree that improvements in multiparametric radial velocity (RV) modeling are necess
272                           Interestingly, the multiparametric readout allowed for the differentiation
273                                          The multiparametric readout takes into account the intrinsic
274 lied to fluorescence-based assays to extract multiparametric readouts of treatment effects for hetero
275                                              Multiparametric regression analyses showed that in COVID
276  delivered high-performance mapping of these multiparametric relationships.
277                          Purpose To generate multiparametric response map (mPRM) measurements in ex-s
278                                   Conclusion Multiparametric response maps revealed two abnormal stru
279 riuretic peptide) levels are included in the multiparametric risk assessment approach for pulmonary a
280 and high NT-proBNP categories as part of the multiparametric risk assessment approach outlined in the
281 ill discuss these methods with a view toward multiparametric risk assessment in DCM with the hope of
282  of CD94(+) (KLRD1(+)) NK cells in NHP using multiparametric RNA flow cytometry.
283 e previously developed a reliable method for multiparametric scaling of Fermi contacts to achieve fas
284                                          The multiparametric scan protocol assessed hepatic (T1 and T
285                                          The multiparametric schemes yielded AUC(ImageFusion) = 0.85
286                                     A simple multiparametric scoring function (AB-MPS) was devised th
287 he performance of the proposed CNN-LSTM with multiparametric sequence data was found to outperform th
288                                            A multiparametric sequence-specific model for predicting p
289   Mass cytometry is developing as a means of multiparametric single-cell analysis.
290                                              Multiparametric single-cell mass cytometry demonstrates
291 al snapshots soon after DU onset, this novel multiparametric statistical approach for comparative epi
292 Partial Least Squares Discriminant Analysis) multiparametric statistical methods allowed the cocoa be
293                                              Multiparametric structural analysis of these aptamers re
294                   All participants underwent multiparametric structural and functional magnetic reson
295                             We established a multiparametric structure-activity relationship, allowin
296 maging approach could enable high-resolution multiparametric tissue quantification within clinically
297 rpose To evaluate the diagnostic accuracy of multiparametric ultrasonography (US) consisting of gray-
298                                   Conclusion Multiparametric US allows for a reliable differentiation
299                                         When multiparametric volumes from two observers were combined
300                  Feature matrices mapped the multiparametric voxel values in the vicinity of the biop

 
Page Top